Dambkowski Carl's Form 4 filing
Apogee Therapeutics, Inc. (APGE) · filed Jan 9, 2026
- Accession no.
- 0001104659-26-002574
- Filed
- Jan 9, 2026
- Trade date
- Jan 7, 2026
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Checked
This filing lists 5 non-derivative transactions and 1 derivative transaction. Open-market sales total $1.46M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Dambkowski CarlCIK 0001983476 | Officer (Chief Medical Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 7, 2026 | Common Stock | MOption exerciseAcquired | +14,025 | $22.86 | +$320,611.5 | 231,223 | Direct | |
| Jan 7, 2026 | Common Stock | SSaleDisposed | −2,954 | $77.13 | −$227,842.02 | 228,269 | Direct | |
| Jan 7, 2026 | Common Stock | SSaleDisposed | −14,820 | $77.90 | −$1,154,478 | 213,449 | Direct | |
| Jan 7, 2026 | Common Stock | SSaleDisposed | −826 | $79.04 | −$65,287.04 | 212,623 | Direct | |
| Jan 7, 2026 | Common Stock | SSaleDisposed | −100 | $80.06 | −$8,006 | 212,523 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 7, 2026 | Common Stock | MOption exerciseDisposed | −14,025 | $0.00 | $0 | 139,540 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.